Search Results - "Berrocal Jaime, A"

Long-term outcomes of induction chemotherapy followed by chemoradiotherapy vs chemoradiotherapy alone as treatment of unresectable head and neck cancer: follow-up of the Spanish Head and Neck Cancer Group (TTCC) 2503 Trial by Hitt, R., Iglesias, L., López-Pousa, A., Berrocal-Jaime, A., Grau, J. J., García-Girón, C., Martínez-Trufero, J., Guix, M., Lambea-Sorrosal, J., del Barco-Morillo, E., León-Vintró, X., Cunquero-Tomas, A. J., Baste, N., Ocaña, A., Cruz-Hernández, J. J.

“…Background Our previous phase-3 study (TTCC 2503) failed to show overall survival advantage of 2 induction chemotherapy (IC) regimens followed by standard…”
Get full text

Cutaneous sarcoidosis in a melanoma patient under Ipilimumab therapy by Martínez Leboráns, L., Esteve Martínez, A., Victoria Martínez, A. M., Alegre de Miquel, V., Berrocal Jaime, A.

Get full text

Phase II multicenter, single arm, open label study of nivolumab in combination with ipilimumab in untreated patients with metastatic uveal melanoma (GEM1402.NCT02626962) by Piulats Rodriguez, J.M., De La Cruz Merino, L., Espinosa, E., Alonso Carrión, L., Martin Algarra, S., López-Castro, R., Curiel García, M.T., Rodriguez Abreu, D., Rullan Iriarte, A.J., Berrocal Jaime, A.

Get full text

Safety and efficacy of nivolumab (nivo) in platinum-refractory recurrent/metastastic head and neck squamous cell (PR R/M HNSCC) patients (pts): Real-life experience by Bruixola, G., Caballero Daroqui, J., Cunquero Tomas, A.J., Sandiego, S., García Sánchez, J., Blasco, S., Ochenduszko, S., Iranzo, A., Lavernia, J., Berrocal Jaime, A., Pastor Borgoñón, M.

Get full text

Determination of DPYD polymorphisms before treatment with chemotherapy with a pyrimidine: Should we continue doing it? by Avila Andrade, C, Cunquero Tomas, A J, Fernandez Diaz, A B, Meri Abad, M, Condori Farfan, L D, Shaheen, I, Cervantes Garcia, S, Safont Aguilera, M J, Iranzo Gonzalez-Cruz, V, Sforza, V, Caballero, C, Godes de Bremond, M C, Gil, M, Aparisi Aparisi, F D A, Blasco Cordellat, A, Berrocal Jaime, A, Ferrer Bolufer, I, Lobo de Mena, M, Marcaida Benito, G, Camps, C

Get full text

1075PSafety and efficacy of nivolumab (nivo) in platinum-refractory recurrent/metastastic head and neck squamous cell (PR R/M HNSCC) patients (pts): Real-life experience by Bruixola, G, Caballero Daroqui, J, Cunquero Tomas, A J, Sandiego, S, García Sánchez, J, Blasco, S, Ochenduszko, S, Iranzo, A, Lavernia, J, Berrocal Jaime, A, Pastor Borgoñón, M

Get full text

1247PDPhase II multicenter, single arm, open label study of nivolumab in combination with ipilimumab in untreated patients with metastatic uveal melanoma (GEM1402.NCT02626962) by Piulats Rodriguez, J M, De La Cruz Merino, L, Espinosa, E, Alonso Carrión, L, Martin Algarra, S, López-Castro, R, Curiel García, M T, Rodriguez Abreu, D, Rullan Iriarte, A J, Berrocal Jaime, A

Get full text

562PDetermination of DPYD polymorphisms before treatment with chemotherapy with a pyrimidine: Should we continue doing it? by Avila Andrade, C, Cunquero Tomas, A J, Fernandez Diaz, A B, Meri Abad, M, Condori Farfan, L D, Shaheen, I, Cervantes Garcia, S, Safont Aguilera, M J, Iranzo Gonzalez-Cruz, V, Sforza, V, Caballero, C, Godes de Bremond, M C, Gil, M, Aparisi Aparisi, F D A, Blasco Cordellat, A, Berrocal Jaime, A, Ferrer Bolufer, I, Lobo de Mena, M, Marcaida Benito, G, Camps, C

Get full text

Cutaneous sarcoidosis in a melanoma patient under Ipilimumab therapy: Sarcoidosis induced by Ipilimumab therapy by Martínez Leboráns, L., Esteve Martínez, A., Victoria Martínez, A. M., Alegre de Miquel, V., Berrocal Jaime, A.

Get full text

Cutaneous sarcoidosis in a melanoma patient under Ipilimumab therapy by Martínez Leboráns, L., Esteve Martínez, A., Victoria Martínez, A. M., Alegre de Miquel, V., Berrocal Jaime, A.

Get full text

Second-line treatment with gemcitabine and vinorelbine in non-small-cell lung cancer (NSCLC) cisplatin failures: a pilot study by Herrero, Carlos Camps, Noguerón Martı́nez, Esther, Jaime, Alfonso Berrocal

“…Purpose: This pilot study was designed to evaluate the efficacy and toxicity of the gemcitabine/vinorelbine combination in non-small-cell lung cancer (NSCLC)…”
Get full text

Corrigendum to “Second line treatment with gemcitabine and vinorelbine in non-small-cell lung cancer (NSCLC) cisplatin failures: a pilot study”: [Lung Cancer 27 (2000) 47–53] by Camps, Carlos, Noguerón Martı́nez, Esther, Berrocal Jaime, Alfonso

Get full text

Cutaneous sarcoidosis in a melanoma patient under Ipilimumab therapy by Martínez Leboráns, L, Esteve Martínez, A, Victoria Martínez, A M, Alegre de Miquel, V, Berrocal Jaime, A

Get full text

Hematopoietic growth factors and anaphylaxis by Balaguer, A A, Berrocal Jaime, A, Noguerón Martínez, E, Camps Herrero, C

Get more information

Interleukin-2 and adoptive immunotherapy: their biological aspects and clinical application in oncology by Barón Saura, J M, Pizarro Redondo, A, Berrocal Jaime, A, González Barón, M

“…Interleukin-2 (IL2), as a modifier of the biological response, has been intravenously used in patients with advanced cancer associated or not to LAK cells or…”
Get more information